Serum 25-hydroxyvitamin D and fatty acids in relation to the risk of microbial infections in children: The TRIGR Divia study
Leena Hakola(Tampere University), Suvi Μ. Virtanen(Finnish Institute for Health and Welfare), Jarno Honkanen(University of Helsinki), Leena Puustinen(Tampere University), Amir‐Babak Sioofy‐Khojine(Tampere University), Iris Erlund(Finnish Institute for Health and Welfare), Maarit Oikarinen(Tampere University), David Cuthbertson(University of South Florida), Jeffrey P. Krischer(University of South Florida), Jussi Lehtonen(University of Jyväskylä), Mikael Knip(Åbo Akademi University), Sari Niinistö(University of Helsinki), Heikki Hyöty(Tampere University of Applied Sciences)
Cited by 13
Related Papers
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
|Cell Host & Microbe|2015|1.2k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability
|Science Translational Medicine|2016|1.1k